bromperidol has been researched along with Basal Ganglia Diseases in 3 studies
bromperidol: bromine-substituted for chlorine in haloperidol; RN given refers to unlabeled parent cpd; structure
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We have presented pharmacokinetic parameters of bromperidol (BP) in 14 healthy Korean subjects." | 2.72 | Pharmacokinetic parameters of bromperidol in Korean subjects. ( Kim, HG; Kim, JW; Kim, YG; Lee, SY, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Perquin, LN | 1 |
| Lee, SY | 1 |
| Kim, YG | 1 |
| Kim, HG | 1 |
| Kim, JW | 1 |
| Furukori, H | 1 |
1 trial available for bromperidol and Basal Ganglia Diseases
| Article | Year |
|---|---|
Pharmacokinetic parameters of bromperidol in Korean subjects.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A | 2006 |
2 other studies available for bromperidol and Basal Ganglia Diseases
| Article | Year |
|---|---|
Treatment with the new antipsychotic sertindole for late-occurring undesirable movement effects.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Clopenthixol; Female; Haloperidol; Humans; Imid | 2005 |
[Involvement of cytochromeP4503A4 in the metabolism of haloperidol and bromperidol].
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Cytochrome P-450 CYP3A; Cytochrome P-450 | 1998 |